Home › Medicines › S-Kinase
S-Kinase

S-Kinase

Powder for Injection

🧬 Streptokinase 🏢 Popular Pharmaceuticals Ltd.
Generic Name Streptokinase
Manufacturer Popular Pharmaceuticals Ltd.
Unit Price 1.5 million unit vial: ৳ 4,500.00

🔹 Indications

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

🔹 Pharmacology

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

🔹 Dosage & Administration

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

🔹 Interaction

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

🔹 Contraindications

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

🔹 Side Effects

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

🔹 Pregnancy & Lactation

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

🔹 Precautions & Warnings

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

🔹 Storage Conditions

S-Kinase is indicated for:

Systemic administration-
  • acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block
  • deep vein thromboses (not older than 14 days)
  • acute massive pulmonary embolism
  • acute and subacute thromboses of peripheral arteries
  • chronic occlusive arterial diseases (not older than 6 weeks)
  • occlusion of central retinal artery or vein (arterial occlusions not older than 6 to 8 hours, venous occlusions not older than 10 days).
Local administration-
  • acute myocardial infarction for re-opening of coronary vessels (not older than 12 hours)
  • acute, subacute and chronic thromboses as well as embolisms of peripheral venous and arterial vessels.

💡 Frequently Asked Questions

S-Kinase is indicated for:Systemic administration- acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block deep vein thromboses (not older than 14 days) acute massive...
S-Kinase is indicated for:Systemic administration- acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block deep vein thromboses (not older than 14 days) acute massive...
S-Kinase is indicated for:Systemic administration- acute transmural myocardial infarction (not older than 12 hours), with persistent ST-segment elevation or recent left bundle-branch block deep vein thromboses (not older than 14 days) acute massive...

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review